- Investigator
- Neha Agrawal
- Ages
- 18 Years - NA Years
- Sexes
- All
Clinical trials
-
VANTAGE study -
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis - Ages
- 18 Years - 75 Years
- Sexes
- All
-
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
Phase III, randomized, double-blind, placebo-controlled study to assess BI 1291583 2.5 mg once daily for up to 76 weeks in patients with bronchiectasis - Investigator
- Michael D Schweitzer Barrios
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
A Natural History and Outcome Measure Discovery Study of PRPF31 Mutation–Associated Retinal Dystrophy (20226317) - Investigator
- Sandeep Grover
- Ages
- N/A
- Sexes
- All
-
A Phase 2/3, Randomized, Controlled, Masked, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Two Doses of AGTC-501, a Recombinant Adeno-associated Virus Vector Expressing RPGR (rAAV2tYF-GRK1-RPGR), Compared to an Untreated Control - Investigator
- Sandeep Grover
- Ages
- 12 Years - 50 Years
- Sexes
- Male
-
EVOLVE-MI - Ages
- 18 Years - N/A
- Sexes
- All
-
TAILOR BLEED - Investigator
- Dominick J Angiolillo
- Ages
- N/A
- Sexes
- All
-
Non-invasive vagal nerve stimulation and sleep - Investigator
- Mariam Louis
- Ages
- 18 Years - 55 Years
- Sexes
- All
-
The American Lung Association (ALA) Lung Health Cohort (LHC) - Investigator
- Vandana K Seeram
- Ages
- 25 Years - 35 Years
- Sexes
- All